Edition:
India

Adverum Biotechnologies Inc (ADVM.OQ)

ADVM.OQ on NASDAQ Stock Exchange Global Market

3.03USD
22 Nov 2017
Change (% chg)

$0.03 (+0.83%)
Prev Close
$3.00
Open
$3.05
Day's High
$3.05
Day's Low
$3.00
Volume
3,717
Avg. Vol
40,662
52-wk High
$4.20
52-wk Low
$2.45

Chart for

About

Adverum Biotechnologies, Inc., formerly Avalanche Biotechnologies, Inc., is a gene therapy company. The Company is engaged in discovering and developing medicines to patients suffering from chronic or debilitating disease. The Company operates and manages its business in the segment of developing and commercializing gene... (more)

Overall

Beta: --
Market Cap(Mil.): $153.67
Shares Outstanding(Mil.): 43.29
Dividend: --
Yield (%): --

Financials

BRIEF-Adverum Biotechnologies posts Q3 loss of $0.32 per share

* Adverum biotechnologies reports third quarter 2017 financial results and provides corporate update

09 Nov 2017

BRIEF-Adverum Biotechnologies says has increased size of board to eight members

* Adverum Biotechnologies Inc - increased size of board to eight members - SEC filing Source text: [http://bit.ly/2eKPWc0] Further company coverage:

08 Sep 2017

BRIEF-Adverum Biotechnologies files for mixed shelf of up to $150 mln

* Adverum Biotechnologies Inc files for mixed shelf of up to $150 million - ‍​sec filing Source text: (http://bit.ly/2wyLc11) Further company coverage:

11 Aug 2017

BRIEF-Adverum Biotechnologies Q2 loss per share $0.27

* Adverum Biotechnologies reports second quarter 2017 financial results and provides update

09 Aug 2017

Earnings vs. Estimates